Literature DB >> 4302727

Post-tetanic and drug-induced repetitive firing in the soleus muscle of the cat.

W C Bowman, A A Goldberg, C Raper.   

Abstract

1. The effects of a high frequency indirect tetanus on the responses to subsequent infrequently applied nerve shocks have been compared in the tibialis anterior and soleus muscles of cats and rabbits.2. Post-tetanic augmentation of twitches in the cat soleus muscle was shown to be partly due to repetitive firing and partly due to increased synchronization of the muscle fibre response. Post-tetanic repetitive firing was not evident in the responses of the other three muscles studied.3. Post-tetanic repetitive responses in the cat soleus muscle and nerve did not originate in the nerve trunk and were not produced by direct muscle stimulation; they were abolished by doses of tubocurarine smaller than those necessary to reduce the twitch tension below the pre-tetanic level. These findings support the conclusion of others that the repetitive firing originates at the neuromuscular junction.4. The repetitive firing could not be explained by an increase in the sensitivity of the motor endplates to acetylcholine, suggesting that an increase in and/or a prolongation of the output of transmitter from the motor nerve contributes to it.5. The cat soleus muscle was shown to be more sensitive to neostigmine than were the other three muscles studied, and acetylcholinesterase determinations showed that this muscle possesses less enzyme activity.6. It is concluded that an increase in transmitter output, coupled with a weaker cholinesterase activity, probably accounts for the post-tetanic repetitive activity in the cat soleus muscle.7. Post-tetanic repetitive firing was absent in cat soleus muscles which had been cross-innervated with the nerve formerly innervating a fast-contracting muscle.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4302727      PMCID: PMC1703081          DOI: 10.1111/j.1476-5381.1969.tb07967.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  THE ACTIONS OF SUCCINYLCHOLINE ON THE MAMMALIAN MOTOR NERVE TERMINAL.

Authors:  F G STANDAERT; J E ADAMS
Journal:  J Pharmacol Exp Ther       Date:  1965-07       Impact factor: 4.030

2.  Neuromuscular facilitation and antidromic discharges in motor nerves: their relation to activity in motor nerve terminals.

Authors:  G WERNER
Journal:  J Neurophysiol       Date:  1960-03       Impact factor: 2.714

3.  The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat.

Authors:  W C BOWMAN; E ZAIMIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

4.  Potential changes recorded inside primary afferent fibres within the spinal cord.

Authors:  J C ECCLES; K KRNJEVIC
Journal:  J Physiol       Date:  1959-12       Impact factor: 5.182

5.  Mobilization of transmitter by hyperpolarization.

Authors:  J I HUBBARD; W D WILLIS
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

6.  The effects of activity on mammalian nerve fibres of low conduction velocity.

Authors:  G L BROWN; O HOLMES
Journal:  Proc R Soc Lond B Biol Sci       Date:  1956-03-27

7.  Changes in end-plate activity produced by presynaptic polarization.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

8.  Pharmacological experiments on mammalian voluntary muscle, in relation to the theory of chemical transmission.

Authors:  Z M Bacq; G L Brown
Journal:  J Physiol       Date:  1937-02-19       Impact factor: 5.182

9.  Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl p-nitrophenyl thiophosphate (E 605) and analogues.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1950-04       Impact factor: 3.857

10.  The effect of acetylcholine upon mammalian motor nerve terminals.

Authors:  J I Hubbard; R F Schmidt; T Yokota
Journal:  J Physiol       Date:  1965-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.